Archive for immunology
Humble cells in a little-known organ manage brain inflammation
Deep in the brain, sheets of tissue known as the choroid plexus produce cerebrospinal fluid (CSF) and act as a protective barrier between the brain and CSF. But the lab of Maria Lehtinen, PhD, at Boston Children’s Hospital has shown that the little-known choroid plexus does much more. For example, it secretes factors that promote ... Read More about Humble cells in a little-known organ manage brain inflammation
Creating the next generation of mRNA vaccines
During the COVID-19 pandemic, mRNA vaccines came to the rescue, developed in record time and saving lives worldwide. Researchers in the Precision Vaccines Program at Boston Children’s Hospital have developed two novel technologies that could make these and future mRNA vaccines more potent and longer-lasting — at smaller doses and with fewer side effects. The ... Read More about Creating the next generation of mRNA vaccines
Boosting vaccines for the elderly with ‘hyperactivators’
As we age our immune systems start to flag, leaving us more susceptible to cancer and infections — and less responsive to vaccines and cancer immunotherapies. Going to the heart of the problem, Jonathan Kagan, PhD, a researcher in immunology at Boston Children’s Hospital, has identified a way to rejuvenate the elderly immune system. His ... Read More about Boosting vaccines for the elderly with ‘hyperactivators’
A deeper understanding of inflammatory pain could reveal new solutions
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are the main go-to for inflammatory pain caused by wounds, infection, sunburn, arthritis, and other triggers. NSAIDs work pretty well, but chronic use can cause side effects, and they aren’t equally effective for all sources of pain. Could we identify a more effective, safer analgesic that doesn’t involve ... Read More about A deeper understanding of inflammatory pain could reveal new solutions
Could we intervene in Huntington’s disease before symptoms appear?
Huntington’s disease is the most common single-gene neurodegenerative disorder and is characterized by motor and cognitive deficits and psychiatric symptoms. Work led by Beth Stevens, PhD, and Dan Wilton, PhD, in the Department of Neurology at Boston Children’s Hospital, now shows that the disease process begins well before symptoms appear. That raises the possibility of ... Read More about Could we intervene in Huntington’s disease before symptoms appear?
From bench to bedside: A promising option for unremitting ulcerative colitis
Many existing treatments for inflammatory bowel disease, like Remicade® and Humira®, work by blocking inflammatory cytokines such as tumor necrosis factor (TNF) and interleukins IL-12 and IL-23, which are over-produced in autoimmune disease. But few patients with ulcerative colitis get complete relief from these drugs. A small but promising open-label clinical trial, published recently in ... Read More about From bench to bedside: A promising option for unremitting ulcerative colitis
Taming vaccine data: Joann Arce, PhD
Part of an ongoing series profiling researchers at Boston Children’s Hospital. Joann Arce, PhD, is a data tamer — corralling and wrangling vast quantities of data to extract insights on how our immune systems react to vaccines and infections. Her work is paving a path toward smarter, more potent vaccines. As lead of data management ... Read More about Taming vaccine data: Joann Arce, PhD
An unexpected journey reveals a potent way to attack tumors
Research on the effects of prenatal exposure to the Zika virus has yielded an unexpected dividend: a potentially promising way to trigger natural killer (NK) cells to fight cancer. NK cells are first-responder immune cells. When enough of their activating receptors are triggered, they mobilize to kill infected, stressed, or cancerous cells at an early ... Read More about An unexpected journey reveals a potent way to attack tumors
A promising target for ALS and other neurodegenerative disorders: Curbing inflammation
When cells recognize a danger, such as an infection, they activate the innate immune system. Sentinel molecules sound an alarm, recruiting immune cells to take down the threat. In 2016, Judy Lieberman, MD, PhD and her colleagues at Boston Children’s Hospital showed that a protein called gasdermin D initiates a final, decisive step: pyroptosis, a ... Read More about A promising target for ALS and other neurodegenerative disorders: Curbing inflammation
What every family should know about RSV
To help keep your family safe and informed about respiratory syncytial virus (RSV), we spoke to Dr. Kathleen Conroy, Clinical Chief for Children’s Hospital Primary Care Center (CHPCC). What is RSV and what are the symptoms? RSV is a virus that causes upper and lower respiratory tract infections, most commonly in children and infants; however, ... Read More about What every family should know about RSV